← Leaderboards
Alfredo Quinones-Hinojosa
Mayo Clinic Jacksonville
$11,576,760
Attributed
$18,161,765
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,161,765 · 12
By mechanism
R01$16,162,517 · 8
K08$879,702 · 1
R33$770,544 · 1
R43$300,000 · 1
F32$49,002 · 1
Top collaborators
- Jordan Green8 shared
- Konstantinos Konstantopoulos5 shared
- Xingde Li5 shared
- Honggang Cui3 shared
- Debabrata Mukhopadhyay3 shared
- Y. Shrike Zhang3 shared
- Kaisorn Lee Chaichana2 shared
- Robert Graham Cooks2 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- Hugo Guerrero-Cazares$2,987,288
- Debabrata Mukhopadhyay$19,437,696
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoGlioblastomaBrain NeoplasmsBrainCellsOperative Surgical ProceduresTumorMalignant Neoplasm Of BrainIn VitroGliomaMalignant NeoplasmsCancer CellRadiation TherapyFutureCell MotilityLeadClinical TrialsRecurrenceExcisionCharacteristicsAdultPrimary Brain NeoplasmsNeoplastic CellTechnology
Grant awards (49)
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma$556,541
R01 · FY2025 · NS · contact PI
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma$529,515
R01 · FY2025 · CA
A Bioprinted Volumetric Model of Vascularized Glioblastoma$426,834
R01 · FY2025 · CA
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma$599,828
R01 · FY2024 · NS · contact PI
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma$502,940
R01 · FY2024 · CA
A Bioprinted Volumetric Model of Vascularized Glioblastoma$405,493
R01 · FY2024 · CA
Tumor targeted drug delivery nanoplatform to overcome therapy resistance glioblastoma$618,380
R01 · FY2023 · NS · contact PI
Self-Assembling Camptothecin Nanofiber Hydrogels as Adjunct Therapy for Intraoperative Treatment of Malignant Glioma$521,070
R01 · FY2023 · CA
A Bioprinted Volumetric Model of Vascularized Glioblastoma$446,380
R01 · FY2023 · CA
A novel microfluidic device to predict brain cancer prognosis and response to therapy$462,728
R01 · FY2022 · CA · contact PI
A novel microfluidic device to predict brain cancer prognosis and response to therapy$474,770
R01 · FY2021 · CA · contact PI
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies$378,398
R33 · FY2021 · CA
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging$594,394
R01 · FY2020 · CA
A novel microfluidic device to predict brain cancer prognosis and response to therapy$477,368
R01 · FY2020 · CA · contact PI
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies$392,146
R33 · FY2020 · CA
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)$363,722
R01 · FY2020 · CA · contact PI
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging$589,760
R01 · FY2019 · CA
A novel microfluidic device to predict brain cancer prognosis and response to therapy$465,567
R01 · FY2019 · CA · contact PI
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)$352,810
R01 · FY2019 · CA · contact PI
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$312,527
R01 · FY2019 · CA · contact PI
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)$9,910
R01 · FY2019 · CA · contact PI
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging$615,799
R01 · FY2018 · CA
A novel microfluidic device to predict brain cancer prognosis and response to therapy$496,519
R01 · FY2018 · CA · contact PI
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)$363,623
R01 · FY2018 · CA · contact PI
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$322,194
R01 · FY2018 · CA · contact PI
Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy$300,000
R43 · FY2018 · CA
Administrative Supplement: Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer$55,777
R01 · FY2018 · CA · contact PI
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging$616,337
R01 · FY2017 · CA
Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer (Change of Organization Application)$364,553
R01 · FY2017 · CA · contact PI
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$322,194
R01 · FY2017 · CA · contact PI
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$133,280
R01 · FY2017 · CA · contact PI
Nanoparticle modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer$10,280
R01 · FY2017 · CA
Intra-Operative, Label-Free Detection of Brain Cancer Infiltration with Quantitative Optical Imaging$551,146
R01 · FY2016 · CA
Nanoparticle modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer$370,575
R01 · FY2016 · CA
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$333,518
R01 · FY2016 · CA · contact PI
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$137,964
R01 · FY2016 · CA · contact PI
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma$329,461
R01 · FY2015 · CA · contact PI
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation$485,447
R01 · FY2014 · NS · contact PI
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation$464,279
R01 · FY2013 · NS · contact PI
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation$52,277
R01 · FY2013 · NS · contact PI
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation$447,623
R01 · FY2012 · NS · contact PI
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation$481,753
R01 · FY2011 · NS · contact PI
Role of NKCC1 on Brain Tumor Stem Cell Migration After EGF and Slit-2 Stimulation$497,381
R01 · FY2010 · NS · contact PI
Migration of Human Neural Stem Cells In Vitro and In Vivo$176,094
K08 · FY2010 · NS · contact PI
Migration of Human Neural Stem Cells In Vitro and In Vivo$176,094
K08 · FY2009 · NS · contact PI
Migration of Human Neural Stem Cells In Vitro and In Vivo$176,094
K08 · FY2008 · NS · contact PI
Migration of Human Neural Stem Cells In Vitro and In Vivo$176,094
K08 · FY2007 · NS · contact PI
Migration of Human Neural Stem Cells In Vitro and In Vivo$175,326
K08 · FY2006 · NS · contact PI
Neurogenesis in the Human Brain$49,002
F32 · FY2003 · NS